The status quo is dependence on paid plasma, we import about 80% of our plasma from the US, because you don't get enough donors when you don't compensate them. Everyone else in the donation chain gets compensated (phlebotomists, doctors, nurses, receptionist...), and there's nothing wrong with compensating the donor as well.
The status quo is dependence on paid plasma, we import about 80% of our plasma from the US, because you don't get enough donors when you don't compensate them. Everyone else in the donation chain gets compensated (phlebotomists, doctors, nurses, receptionist...), and there's nothing wrong with compensating the donor as well.